Journal of Leukocyte Biology Myeloid cells, immune suppression, tumor immunology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.1107768 on July 8, 2008

Published online before print July 8, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1107768v1
84/3/644    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Varga, G.
Right arrow Articles by Sunderkoetter, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varga, G.
Right arrow Articles by Sunderkoetter, C.
(Journal of Leukocyte Biology. 2008;84:644-650.)
© 2008 by Society for Leukocyte Biology

Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells

Georg Varga*,{dagger},1, Jan Ehrchen*,{dagger},1, Athanasios Tsianakas*,{dagger}, Klaus Tenbrock*,{ddagger}, Anke Rattenholl{dagger}, Stephan Seeliger{ddagger}, Matthias Mack§, Johannes Roth*,{ddagger} and Cord Sunderkoetter*,{dagger},2

* Institute of Immunology and Departments of
{dagger} Dermatology and
{ddagger} Pediatrics, University of Muenster, Muenster, Germany; and
§ Department of Internal Medicine II, University Hospital of Regensburg, Regensburg, Germany

2 Correspondence: Department of Dermatology, University of Muenster, Von Esmarch Str. 58, Muenster D-48149, Germany. E-mail: cord.sunderkoetter{at}ukmuenster.de

ABSTRACT

Glucocorticoids (GC) are still the most widely used immunosuppressive agents in clinical medicine. Surprisingly, little is known about the mechanisms of GC action on monocytes, although these cells exert pro- and anti-inflammatory effects. We have shown recently that GC induce a specific monocyte phenotype with anti-inflammatory properties in humans. We now investigated whether this also applies for the murine system and how this subset would relate to recently defined murine subtypes. After treatment with dexamethasone for 48 h, monocytes up-regulated scavenger receptor CD163 and Gr-1, down-regulated CX3CR1, and shared with human GC-treated monocytes functional features such as low adhesiveness but high migratory capacity. They specifically up-regulated anti-inflammatory IL-10, but not TGF-β, and in contrast to their human counterparts, they down-regulated IL-6. Although GC-induced monocytes down-regulated CX3CR1, a distinctive marker for classical/proinflammatory human and murine monocytes (CX3CR1loCCR2+Ly6Chi), they differed from this physiologically occurring subset, as they remained Ly6Cmed and unactivated (CD62 ligand++). In addition to their immunosuppressive effects, they were CD11b+Gr-1+ and expressed the IL-4R{alpha} chain (CD124), a recently described, signature molecule of tumor-induced myeloid-derived suppressor cells (MDSC). We therefore generated murine MDSC in B16 melanoma-bearing mice and indeed found parallel up-regulation of CD11b+Gr-1+ and CD124 on GC-induced monocytes and MDSC. These data allow us to speculate that the GC-induced subtype shares with inflammatory monocytes the ability to migrate quickly into inflamed tissue, where they, however, exert anti-inflammatory effects and that similarities between GC-induced monocytes and MDSC may be involved in progression of some tumors observed in patients chronically treated with GC.

Key Words: IL-10 • CD124







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society for Leukocyte Biology.